GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Artemis Medicare Services ARTEMISMED.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

308.45

+0.77%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2025

Revenue

₹9.37bn

FY2019FY2025

Net income

₹826.3m

FY2019FY2025

Free cash flow

₹524.7m

FY2019FY2025

Shareholders' equity

₹8.38bn

FY2019FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue₹9.37bn₹8.79bn₹7.37bn₹5.55bn₹4.08bn₹5.65bn₹5.47bn
Operating income₹1.07bn₹924.4m₹631.7m₹457.8m₹139.3m₹391.2m₹437.4m
Net income₹826.3m₹491.4m₹386.0m₹318.1m₹64.9m₹197.9m₹204.9m
Diluted earnings per share5.313.532.792.290.491.501.55

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assets₹13.57bn₹9.72bn₹9.05bn₹7.10bn₹6.00bn₹5.86bn—
Cash and short-term investments₹4.16bn₹682.2m₹578.1m₹335.8m₹357.5m₹192.6m—
Total liabilities₹5.20bn₹5.23bn₹5.02bn₹3.50bn₹2.80bn₹2.73bn—
Debt₹2.90bn₹3.20bn₹2.86bn₹2.01bn₹1.47bn₹1.13bn—
Shareholders' equity₹8.38bn₹4.48bn₹4.03bn₹3.59bn₹3.20bn₹3.13bn—
Shares outstanding156m139m139m139m132m132m132m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations₹1.46bn₹2.24bn₹1.27bn₹595.8m₹272.6m₹560.8m—
Capital spending−₹931.5m−₹725.5m−₹1.46bn−₹1.09bn−₹345.0m−₹260.0m—
Free cash flow₹524.7m₹1.51bn−₹193.1m−₹493.2m−₹72.4m₹300.8m—
Dividends paid−₹59.8m−₹61.1m—————

Latest quarters

By quarter end

Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023
Revenue₹2.75bn₹2.55bn₹2.40bn₹2.32bn₹2.41bn₹2.23bn₹2.25bn₹2.19bn
Operating income₹389.1m₹302.4m₹242.0m₹260.0m₹311.0m₹254.0m₹269.1m₹224.8m
Net income₹299.7m₹212.8m₹230.0m₹207.0m₹223.0m₹167.0m₹141.8m₹115.5m
Diluted earnings per share1.891.351.451.311.411.121.020.83
Total assets₹14.26bn—₹13.57bn—₹13.39bn—₹9.71bn—
Cash and short-term investments₹3.64bn—₹4.17bn—₹3.91bn—₹683.6m—
Debt₹2.40bn—₹2.49bn—₹2.76bn—₹2.86bn—
Shareholders' equity₹8.83bn—₹8.38bn—₹7.93bn—₹4.48bn—

Financial ratios

Data as of 20 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin13.0%11.4%10.6%9.5%8.9%3.5%—
Net margin9.6%8.8%5.6%5.2%5.8%1.6%—
Return on equity11.1%9.9%11.0%9.6%8.9%2.0%—
Return on assets7.3%6.1%5.1%4.3%4.5%1.1%—
Free cash flow yield5.1%4.5%3.3%5.5%3.4%1.2%—
Revenue growth15.4%6.6%19.3%33.3%35.6%-26.9%—
Earnings growth25.4%68.1%27.3%21.3%390.5%-67.2%—
Current ratio1.74x2.49x0.98x0.83x0.92x0.92x—
Debt to equity0.04x0.30x0.58x0.61x0.52x0.41x—
Equity ratio65.4%61.7%46.1%44.5%50.6%53.4%—
Interest coverage5.06x3.34x2.99x3.57x4.11x1.12x—
R&D as a share of sales—0.7%1.0%1.0%1.2%1.7%0.3%
Buybacks as a share of market value11.7%-13.4%0.1%-0.9%-4.3%-0.1%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue19.1%10.6%—
Operating income32.6%22.3%—
Net income37.5%33.1%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin11.0%9.9%8.9%—
Net margin7.3%6.5%5.6%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings51.189.164.733.286.115.1
Price to sales4.55.03.41.91.40.5

Dividends and splits

Per share, in the currency the company pays

Paid for 3 years. Last went ex-dividend on 10 Jul 2026.

FY2026FY2025FY2024
Paid in the year0.450.450.45
  • 10-for-1 split · 23 Sept 2021

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.